Ordinaria, Menelisa M.
HRN: 22-70-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/09/2023
03/16/2023
IV
500mg
Q6
DM Foot
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes